Telehealth & Digital Health

A skincare brand is challenging the FDA over sunscreen ingredients, revealing decades of regulatory delay and raising questions about what’s safe for our skin.

Crossroads Counselling expands psychoeducational testing to age 30, addressing a critical gap in care amid long public waits and high academic pressures.

A new report shows hospitals in a federal drug discount program provide less charity care than others, fueling calls for urgent federal reforms.

Colombia invests $260M to regain vaccine independence through a landmark tech transfer deal with South Korea's SK bioscience. A new chapter begins.

A new telehealth platform offers prescription-only CBD, navigating a major regulatory shift that will reshape the entire cannabis industry. Here's what's next.

With strong clinical data for its Dayspring system, Koya Medical is pitching to investors to fund the next phase of growth for its patient-centered tech.

Growth equity firm AVANT BIO adds biomanufacturing legends Maik Jornitz and Lukas Utiger, signaling a shift toward deep operational support for its startups.

A landmark Novo Nordisk study finds 2 in 5 heart patients have hidden inflammation, a major risk for heart attack and stroke despite standard treatments.

Studies reveal an AI platform slashes cancer patient hospitalizations by up to 51% and saves millions, heralding a new era of remote oncology care.

The Vaya Partners merger creates a 47-county giant serving 222,000 people, promising stability but facing huge integration and regulatory challenges.

Motivity's deal to acquire Calmanac creates an all-in-one ABA platform, merging top-tier clinical and operational tech to challenge market leaders.

South Jersey's Virtua Health soars in national rankings, proving that compassion, trust, and human connection are the new benchmarks in modern healthcare.

A landmark survey shows medical cannabis helps 97% of mental health patients, but experts urge caution, highlighting a divide between patient experience and clinical proof.

On the sidelines of the World Health Assembly, three startups won major funding for AI tools that predict outbreaks, find cancer, and empower health workers.

A breakthrough system grows larger, more complex human gut tissues twice as fast, promising to revolutionize drug testing and regenerative medicine.

A revolutionary single-dose, over-the-counter cold sore tablet launches in Europe, promising new convenience for millions and shaking up the self-care market.

Caliway Biopharma advances its fat-loss drug, promising objective, MRI-verified results in a market hungry for safer, more reliable aesthetic options.

Gene Solutions' AI-driven multi-omics liquid biopsy platform makes waves at a major oncology conference, finding a ready market in Taiwan.

At SLAS 2026, MGI Tech unveiled intelligent platforms for proteomics and clinical automation, signaling a major push to accelerate scientific discovery.

Teva's new once-monthly olanzapine injection could revolutionize schizophrenia care in Europe, offering hope for better treatment adherence and patient outcomes.